Peter Marks, the FDA’s vaccines lead, told STAT the agency reached its decision after a recent review of the data on the vaccine revealed another person in this country had died after receiving it — the ninth such death — in the first quarter of the year. With one death for every 2 million doses given […]
A 2020 study from Hong Kong found that 80% of new infections were caused by just 10% to 20% of cases, often in indoor superspreading events. “It’s a reason why some infections are more controllable than others, even for the same reproductive number,” said Benjamin Cowling, an infectious disease epidemiologist at the University of Hong […]
The man, described by Colorado health officials as being younger than 40 years old, experienced only fatigue; he is now in isolation and being treated with the flu antiviral oseltamivir. H5 viruses have long struck fear among scientists who study bird flu because of the economic damage they can wreak and their propensity to occasionally […]
and from Alabama — where nine cases have been recorded since last fall — points to the possible involvement of an adenovirus. In a statement issued late Thursday, the Centers for Disease Control and Prevention said it is working with Alabama on its investigation into the cases, and is working with other state health departments […]
On Monday, the U.S. After a bitter seven-year battle between the Broad and Doudna and Charpentier’s side, known as the CVC group, the patent judges finally issued a definitive opinion on who invented the “guide RNA” molecule that allows the genome editor to work in eukaryotic cells. …Read the full story
The work, by scientists at the National Institutes of Allergy and Infectious Diseases’s Vaccine Research Center, shows that animals boosted with the original vaccine had similar levels of protection against disease in the lungs as did primates that received an updated booster based on the Omicron strain. Senior author Robert Seder said the findings are […]
SAN DIEGO — If DNA is the book of life, there’s a subplot around the race to read genetic information quickly, accurately, and cheaply. Morgan Health Care Conference that it plans to roll out a new technology in the latter half of 2022, dubbed Infinity, which will read DNA in far larger chunks than the firm […]
The surprise departure of Sandrock, who oversees all of Biogen’s research and development, leaves a void in the company’s upper ranks. STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. …Read the full story
“We’re accelerating our path out of this pandemic,” President Biden said after data on the second Covid pill became available. The first results, from Merck and Ridgeback Therapeutics, were released in October and will be considered by an advisory panel to the Food and Drug Administration in December. In November, Pfizer announced that its Covid […]
They aim to improve the entire spectrum of care from prevention to screening, diagnosis, treatment, and continuing care. It has five phases: Technology Trigger, Peak of Inflated Expectations, Trough of Disillusionment, Slope of Enlightenment, and Plateau of Productivity. There have likewise been soaring valuations for early VC-backed companies and a record number of so-called unicorn […]
If you weren’t paying attention — and most people outside of the biotech industry weren’t — the Cambridge company’s shares went nowhere after its initial public offering in late 2018. STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. …Read the full story